Australia markets closed

G Medical Innovations Holdings (GMVDW)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
7.04+7.04 (-1.13%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.00
Open0.55
Bid0.00 x 0
Ask0.00 x 0
Day's range0.51 - 0.55
52-week range0.51 - 0.55
Volume21,608
Avg. volumeN/A
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    G Medical Innovations Will Provide Services to Veterans and Military Personnel by Partnering With Resilient Support Services

    Rehovot, Israel, Aug. 17, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (“G Medical Innovations”), an industry innovator in comprehensive remote patient monitoring solutions, today announced that its wholly-owned subsidiary, G Medical Innovations USA, Inc., has entered into an agreement with Resilient Support Services Inc. (“RSS”) to expand the health care and remote patient monitoring capabilities to U.S. veterans and military personnel. RSS is a Service-Disabled V

  • GlobeNewswire

    G Medical Innovations’ CEO Issues Update to Shareholders, August 2023

    Rehovot, Israel, Aug. 07, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (“G Medical Innovations” or the “Company”), a global leader in next-generation mobile health (mHealth) and digital health, today issued the following update to shareholders from President and CEO Dr. Yacov Geva. Dear Fellow Shareholders, We are proud to report that at this halfway point of 2023, G Medical has met several significant milestones and is on track to show revenue growth and gain prof

  • GlobeNewswire

    G Medical Innovations Holdings Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification

    Rehovot, Israel, May 19, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company”), a telehealth, medical device, and remote patient monitoring company, announced today that on May 15, 2023 it received a written notice (the “Notice”) from Nasdaq Stock Market LLC, indicating that the Company is not in compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a